ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CVSG Cvs Group Plc

975.00
-44.00 (-4.32%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -44.00 -4.32% 975.00 976.00 984.50 1,040.00 980.00 1,040.00 488,057 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 608.3M 41.9M 0.5843 16.81 704.58M

CVS Group plc Exercise of Options (1673K)

31/12/2020 7:00am

UK Regulatory


Cvs (LSE:CVSG)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Cvs Charts.

TIDMCVSG

RNS Number : 1673K

CVS Group plc

31 December 2020

31 December 2020

CVS Group plc

("CVS" or the "Company")

Exercise of Options

CVS, one of the UK's leading providers of integrated veterinary services, confirms that certain employees have exercised options during December under the Company's Save As You Earn (SAYE) 2020 scheme (together, the "SAYE Exercise") totalling 166 ordinary shares of 0.2 pence each ("Ordinary Shares").

The SAYE Exercise was satisfied out of the Company's existing Employee Benefit Trust ("EBT"). As at the date of this announcement, the remaining number of ordinary shares held by the EBT is 18,713 .

The Company's total issued share capital at the date of this announcement therefore remains unchanged at 70,654,959 Ordinary Shares each carrying one voting right.

The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,654,959. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

   CVS Group Plc                                                     Tel: 01379 644288 

Juliet Dearlove, Company Secretary

   N+1 Singer (Nominated Adviser & Broker)    Tel: 020 7496 3000 

Aubrey Powell/ Jen Boorer/ Ben Farrow (Corporate Finance)

Rachel Hayes (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCKKKBBBBDDABN

(END) Dow Jones Newswires

December 31, 2020 02:00 ET (07:00 GMT)

1 Year Cvs Chart

1 Year Cvs Chart

1 Month Cvs Chart

1 Month Cvs Chart

Your Recent History

Delayed Upgrade Clock